Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure
Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diar...
Gespeichert in:
Veröffentlicht in: | Pediatrics (Evanston) 1999-03, Vol.103 (3), p.675-678 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 678 |
---|---|
container_issue | 3 |
container_start_page | 675 |
container_title | Pediatrics (Evanston) |
container_volume | 103 |
creator | Croffie, Joseph M Gupta, Sandeep K Chong, Sonny K. F Fitzgerald, Joseph F |
description | Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point. |
doi_str_mv | 10.1542/peds.103.3.675 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69599015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A54128100</galeid><sourcerecordid>A54128100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-f84aa86c8ef43e9be0b06b9295dd80fc0de900a4049372d13476c918336d6a6c3</originalsourceid><addsrcrecordid>eNpt0s2O0zAQAOAIgdhl4coRWQghDpsyjvN7LNXuslKlHlrE0XKdSeJVagfbWeiJV-FZeDJctVK3qMrBHuuzx55MFL2lMKFZmnwesHYTCmzCJnmRPYsuKVRlnCZF9jy6BGA0TgGyi-iVcw8AkGZF8jK6oGFWVUV5Gf1eba1xSuNGCbLaDkjo3z_Lzox9Tb4gWY5uQOmxJkqTe90I7R35rnxHlviIFsnMiHbszSB8tyU3j6h30HdIpmuHWiIxDVmE2JKlarXbhXMVdpJbofrR4uvoRSN6h28O41X07fZmNfsazxd397PpPJZZDj5uylSIMpclNinDao2whnxdJVVW1yU0EmqsAEQansWKpKYsLXJZ0ZKxvM5FLtlV9HF_7mDNjxGd5xvlJPa90GhGx_MqqyqgWYDv_4MPZrQ63I0nSZlCxoAGdL1HreiRK90Yb4VsUaMVvdHYqLA8zVKalKHUgcdnePjqUHZ5zn868YF4_OVbMTrHy7v5Cb0-R6Xpe2yRhxrOFid8sucy_HVnseGDVRtht5wC3zUU3zVUCBhnPDRU2PDuUI5xvcH6Cd93UAAfDkA4KfrGCi2VO7qClkDTY-JOtd1PZXGXSAlvlXRPpsfE_wAdt-GQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>228405301</pqid></control><display><type>article</type><title>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Croffie, Joseph M ; Gupta, Sandeep K ; Chong, Sonny K. F ; Fitzgerald, Joseph F</creator><creatorcontrib>Croffie, Joseph M ; Gupta, Sandeep K ; Chong, Sonny K. F ; Fitzgerald, Joseph F</creatorcontrib><description>Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.103.3.675</identifier><identifier>PMID: 10049978</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>Elk Grove Village, IL: Am Acad Pediatrics</publisher><subject>Amino Acid Metabolism, Inborn Errors - complications ; Amino Acid Metabolism, Inborn Errors - diagnosis ; Aminoacid disorders ; Babies ; Biological and medical sciences ; Birth defects ; Bleeding ; Blood Coagulation Disorders - complications ; Causes of ; Diagnosis ; Enzymes ; Errors of metabolism ; Female ; Humans ; Infant ; Liver ; Liver diseases ; Liver Failure - complications ; Liver Failure - surgery ; Liver Transplantation ; Male ; Medical disorders ; Medical sciences ; Metabolic diseases ; Metabolism ; Pediatrics ; Physiological aspects ; Proteins ; Transplantation ; Tyrosine - blood ; Tyrosine metabolism</subject><ispartof>Pediatrics (Evanston), 1999-03, Vol.103 (3), p.675-678</ispartof><rights>1999 INIST-CNRS</rights><rights>COPYRIGHT 1999 American Academy of Pediatrics</rights><rights>COPYRIGHT 1999 American Academy of Pediatrics</rights><rights>Copyright American Academy of Pediatrics Mar 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-f84aa86c8ef43e9be0b06b9295dd80fc0de900a4049372d13476c918336d6a6c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1718014$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10049978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Croffie, Joseph M</creatorcontrib><creatorcontrib>Gupta, Sandeep K</creatorcontrib><creatorcontrib>Chong, Sonny K. F</creatorcontrib><creatorcontrib>Fitzgerald, Joseph F</creatorcontrib><title>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.</description><subject>Amino Acid Metabolism, Inborn Errors - complications</subject><subject>Amino Acid Metabolism, Inborn Errors - diagnosis</subject><subject>Aminoacid disorders</subject><subject>Babies</subject><subject>Biological and medical sciences</subject><subject>Birth defects</subject><subject>Bleeding</subject><subject>Blood Coagulation Disorders - complications</subject><subject>Causes of</subject><subject>Diagnosis</subject><subject>Enzymes</subject><subject>Errors of metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Liver Failure - complications</subject><subject>Liver Failure - surgery</subject><subject>Liver Transplantation</subject><subject>Male</subject><subject>Medical disorders</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Metabolism</subject><subject>Pediatrics</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Transplantation</subject><subject>Tyrosine - blood</subject><subject>Tyrosine metabolism</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0s2O0zAQAOAIgdhl4coRWQghDpsyjvN7LNXuslKlHlrE0XKdSeJVagfbWeiJV-FZeDJctVK3qMrBHuuzx55MFL2lMKFZmnwesHYTCmzCJnmRPYsuKVRlnCZF9jy6BGA0TgGyi-iVcw8AkGZF8jK6oGFWVUV5Gf1eba1xSuNGCbLaDkjo3z_Lzox9Tb4gWY5uQOmxJkqTe90I7R35rnxHlviIFsnMiHbszSB8tyU3j6h30HdIpmuHWiIxDVmE2JKlarXbhXMVdpJbofrR4uvoRSN6h28O41X07fZmNfsazxd397PpPJZZDj5uylSIMpclNinDao2whnxdJVVW1yU0EmqsAEQansWKpKYsLXJZ0ZKxvM5FLtlV9HF_7mDNjxGd5xvlJPa90GhGx_MqqyqgWYDv_4MPZrQ63I0nSZlCxoAGdL1HreiRK90Yb4VsUaMVvdHYqLA8zVKalKHUgcdnePjqUHZ5zn868YF4_OVbMTrHy7v5Cb0-R6Xpe2yRhxrOFid8sucy_HVnseGDVRtht5wC3zUU3zVUCBhnPDRU2PDuUI5xvcH6Cd93UAAfDkA4KfrGCi2VO7qClkDTY-JOtd1PZXGXSAlvlXRPpsfE_wAdt-GQ</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>Croffie, Joseph M</creator><creator>Gupta, Sandeep K</creator><creator>Chong, Sonny K. F</creator><creator>Fitzgerald, Joseph F</creator><general>Am Acad Pediatrics</general><general>American Academy of Pediatrics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</title><author>Croffie, Joseph M ; Gupta, Sandeep K ; Chong, Sonny K. F ; Fitzgerald, Joseph F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-f84aa86c8ef43e9be0b06b9295dd80fc0de900a4049372d13476c918336d6a6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Metabolism, Inborn Errors - complications</topic><topic>Amino Acid Metabolism, Inborn Errors - diagnosis</topic><topic>Aminoacid disorders</topic><topic>Babies</topic><topic>Biological and medical sciences</topic><topic>Birth defects</topic><topic>Bleeding</topic><topic>Blood Coagulation Disorders - complications</topic><topic>Causes of</topic><topic>Diagnosis</topic><topic>Enzymes</topic><topic>Errors of metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Liver Failure - complications</topic><topic>Liver Failure - surgery</topic><topic>Liver Transplantation</topic><topic>Male</topic><topic>Medical disorders</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Metabolism</topic><topic>Pediatrics</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Transplantation</topic><topic>Tyrosine - blood</topic><topic>Tyrosine metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Croffie, Joseph M</creatorcontrib><creatorcontrib>Gupta, Sandeep K</creatorcontrib><creatorcontrib>Chong, Sonny K. F</creatorcontrib><creatorcontrib>Fitzgerald, Joseph F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Croffie, Joseph M</au><au>Gupta, Sandeep K</au><au>Chong, Sonny K. F</au><au>Fitzgerald, Joseph F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>103</volume><issue>3</issue><spage>675</spage><epage>678</epage><pages>675-678</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.</abstract><cop>Elk Grove Village, IL</cop><pub>Am Acad Pediatrics</pub><pmid>10049978</pmid><doi>10.1542/peds.103.3.675</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0031-4005 |
ispartof | Pediatrics (Evanston), 1999-03, Vol.103 (3), p.675-678 |
issn | 0031-4005 1098-4275 |
language | eng |
recordid | cdi_proquest_miscellaneous_69599015 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Amino Acid Metabolism, Inborn Errors - complications Amino Acid Metabolism, Inborn Errors - diagnosis Aminoacid disorders Babies Biological and medical sciences Birth defects Bleeding Blood Coagulation Disorders - complications Causes of Diagnosis Enzymes Errors of metabolism Female Humans Infant Liver Liver diseases Liver Failure - complications Liver Failure - surgery Liver Transplantation Male Medical disorders Medical sciences Metabolic diseases Metabolism Pediatrics Physiological aspects Proteins Transplantation Tyrosine - blood Tyrosine metabolism |
title | Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A17%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tyrosinemia%20Type%201%C2%A0Should%20Be%20Suspected%20in%20Infants%20With%20Severe%20Coagulopathy%20Even%20in%20the%20Absence%20of%20Other%20Signs%20of%20Liver%20Failure&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Croffie,%20Joseph%20M&rft.date=1999-03-01&rft.volume=103&rft.issue=3&rft.spage=675&rft.epage=678&rft.pages=675-678&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.103.3.675&rft_dat=%3Cgale_proqu%3EA54128100%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=228405301&rft_id=info:pmid/10049978&rft_galeid=A54128100&rfr_iscdi=true |